BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16773589)

  • 1. [Analysis of adrenocortical tumors morphology as regards their structure and potential malignancy].
    Kajor M; Ziaja J; Król R; Ciupińska-Kajor M; Dobrosz Z; Heitzman M; Cierpka L
    Endokrynol Pol; 2006; 57(2):136-42. PubMed ID: 16773589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.
    Chatterjee G; DasGupta S; Mukherjee G; Sengupta M; Roy P; Arun I; Datta C; Mishra PK; Banerjee S; Chatterjee U
    Pediatr Surg Int; 2015 Jun; 31(6):563-71. PubMed ID: 25895073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.
    Blanes A; Diaz-Cano SJ
    Am J Clin Pathol; 2007 Mar; 127(3):398-408. PubMed ID: 17276949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
    Lau SK; Weiss LM
    Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.
    Stojadinovic A; Brennan MF; Hoos A; Omeroglu A; Leung DH; Dudas ME; Nissan A; Cordon-Cardo C; Ghossein RA
    Mod Pathol; 2003 Aug; 16(8):742-51. PubMed ID: 12920217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ultrastructural criteria of clinical prognosis in hormonally non-active adrenocortical tumors].
    Raĭkhlin NT; Baronin AA; Smirnova EA; Probatova NA; Bronsteĭn MI; Bukaeva IA
    Vopr Onkol; 2003; 49(1):44-50. PubMed ID: 12715369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weiss criteria in large adrenocortical tumors: a validation study.
    Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
    Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative clinical analysis of histological systems of adrenocortical tumors diagnosis].
    Bokhyan VY; Stilidi IS; Pavlovskaya AI
    Vopr Onkol; 2015; 61(6):925-31. PubMed ID: 26995980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adrenocortical tumors with neuroendocrine differentiation].
    Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
    Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of histological and immunohistochemical patterns of benign and malignant adrenocortical tumors by computerized morphometry.
    Dalino Ciaramella P; Vertemati M; Petrella D; Bonacina E; Grossrubatscher E; Duregon E; Volante M; Papotti M; Loli P
    Pathol Res Pract; 2017 Jul; 213(7):815-823. PubMed ID: 28554744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF2 role in adrenocortical carcinoma biology.
    Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
    Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
    Sasano H; Suzuki T; Moriya T
    Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical oncocytic tumors: report of 10 cases and review of the literature.
    Bisceglia M; Ludovico O; Di Mattia A; Ben-Dor D; Sandbank J; Pasquinelli G; Lau SK; Weiss LM
    Int J Surg Pathol; 2004 Jul; 12(3):231-43. PubMed ID: 15306935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
    Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
    Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.
    Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ
    J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating tumor cells in patients with adrenocortical carcinoma: a monocentric preliminary study.
    Pinzani P; Scatena C; Salvianti F; Corsini E; Canu L; Poli G; Paglierani M; Piccini V; Pazzagli M; Nesi G; Mannelli M; Luconi M
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3731-8. PubMed ID: 23836937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
    Blanes A; Diaz-Cano SJ
    Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
    Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
    Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological and molecular features of adrenocortical carcinoma: an update.
    Volante M; Buttigliero C; Greco E; Berruti A; Papotti M
    J Clin Pathol; 2008 Jul; 61(7):787-93. PubMed ID: 18430754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.